All the top Biotech & Pharma news in one daily newsletter.

What to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear from you!📣

(You can also reach out to me on LinkedIn)

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

THE GOOD
Approvals & Labels

Eli Lilly gets all clear from Chinese regulators to sell weight-loss med
GIP/GLP-1, weight-loss, obesity - Read more

Paratek Pharmaceuticals post-marketing study bolsters approval support
Small molecule, antibiotic, pneumonia - Read more

THE GOOD
Business Development

Priovant Therapeutics next on the Roivant spin-out block?
Small molecule, autoimmune, dermatomyositis - Read more [Paywall

Siga Technologies lands a not-so-small $113M US supply contract for smallpox oral antiviral
Small molecule, antiviral, smallpox - Read more

Meitheal Pharmaceuticals secures North America rights to Nabriva Therapeutics’ intravenous antibiotic
Small molecule, broad-spectrum antibiotic - Read more

THE GOOD
Company Launches

Orbimed-funded and assets from China-based Keymed combine to form Belenos Biosciences (plus $50M from an equity round)
Antibody - Read more [Paywall]

THE GOOD
Earnings & Finances

Intuitive Surgical boasts increased sales, but warns of supply constraints
Surgical robot, medical device - Read more

THE GOOD
Fundraises

GRO Biosciences set to GROw into the clinic with a $60.3M series B
Protein therapy, non-standard amino acids, gout - Read more

Rona Therapeutics $35M Series A+
siRNA, hypercholesterolemia, hypertriglyceridemia - Read more

THE GOOD
IPOs

Artiva Biotherapeutics beats their own expectations, raises $167M from IPO
Allogeneic NK cell therapy, autoimmune, systemic lupus erythematosus - Read more

THE GOOD
Mergers & Acquisitions

Dechra Pharmaceuticals to acquire Invetx for up to $520M
Monoclonal antibody, veterinary drug development, animal health - Read more

Morphic spells out courtship that resulted in $3.2B acquisition by Eli Lilly Small molecule, inflammatory bowel disease - Read more

THE GOOD
Regulatory

EMA makes 2024-2025 COVID-19 vaccine recommendations
COVID-19 vaccine, antigenic composition - Read more

ENJOYING THESE NEWSLETTERS?
Consider an optional paid subscription.

It’s a lot of work to put together a daily newsletter, and it’s currently just me writing these things (+ one part-time contractor - no fancy editing team!).

If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.

THE BAD
Earnings & Finance

According to ICER, Pfizer’s ATTR heart disease med needs to be discounted a whopping 96%(!!) before it can be “considered cost-effective under common benchmarks”
Small molecule, heart disease, transthyretin amyloid cardiomyopathy - Read more

THE BAD
Regulatory

Not agreeing to an NMPA (China)-led site inspection means Daewoong Bio gets banned from selling their antibiotic in China
Small molecule, broad spectrum antibiotic - Read more

THE UGLY
Cybersecurity

Crowdstrike IT snafu hits multiple US hospitals and healthcare networks
Healthcare system, hospital network, IT - Read more

THE UGLY
Lawsuits

Vermont attorney general goes after PBMs with new lawsuit
Pharmacy benefit manager, drug prices - Read more

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Want to sponsor this newsletter and reach an audience of 600+ biotech and pharma professionals? Reach us here. 👍

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here.